PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports
Industry News
Kimia Farma already has a strategy to face the MEA: October 2014

PT. Kimia Farma (Persero) expressed readiness to face the Asean Economic Community (AEC) by 2015. Various strategies have been done for the sake of state-owned companies face competition in the MEA.

Director of Research and Business Development Kimia Farma, Wahyuli Syafari said it would improve pharmaceutical manufacturers to face the ASEAN market. "Of course we are ready. The factory we have to improve its market share, one of them is to face the Asean market share," said Wahyuli at the headquarters of Kimia Farma, Veteran, Jakarta, Thursday (16/10).

Other strategies undertaken to address MEA Kimia Farma is to multiply the generic drug development. Therefore, it is rarely done other private pharmaceutical companies.

In addition, the pharmaceutical company also plans to produce raw materials for drugs. This was done because so far Indonesia still imports raw material for making the drug.

"Our strategy is that we develop generic drugs, because if the private-branded its (patent medicines, red). We will also produce raw materials, because of our weakness in the raw material. So far the majority of our imports. If you have the raw materials, that we can absorb, "he said.
Kimia Farma builds pharmaceutical raw material factory, 10 Oktober 2016

In cooperation with Sungwun Pharmacopia of South Korea, Indonesias state-owned pharmaceutical company PT. Kimia Farma will build the first factory for pharmaceutical raw materials to meet the needs of medicine producers in the country.

In building the first factory for pharmaceutical raw materials, Kimia Farma will cooperate with Sungwun Pharmacopia Co. Ltd, because of their experience in producing raw materials for medicines. Kimia Farma will also manufacture seven types of raw materials that can be used for cosmetics and dietary supplements, and to be exported to Korea, Japan and America.

Pharmaceutical, Chemical and Cosmetic Wholesaling in Indonesia
Indonesia Industry Report and Market Research
July 27, 2018
Industry Code : F61334
Forecast to : 2022

Pharmaceutical, Chemical and Cosmetic Wholesaling in Indonesia This Subgroup consists of establishments mainly engaged in wholesaling commodities of the basic chemical industries, various pharmaceutical products and herbal medicine, various types of soap and other cleaning agents, various types of cosmetics, perfume and other colouring agents for hair and skin.
The primary activities of firms in this industry are:
- Wholesaling of medicine and pharmaceutical products.
- Wholesaling of herbal medicine products.
- Wholesaling of caustic soda.
- Wholesaling of Colouring agents.
- Wholesaling of glycerine.
- Wholesaling of insecticides.
- Wholesaling of pesticides.
- Wholesaling of alcohol.
- Wholesaling of volatile oils.
- Wholesaling of soaps and other cleaning agents.
- Wholesaling of cosmetics.
- Wholesaling of perfumes.
- Wholesaling of Colouring agents for hair and skin.
PT. Dataindo Inti SwakarsaTelp : (62 - 21) 719 3832
3rd Floor, Gapura Raya BuildingTelp : (62 - 21) 719 3834
Jl. Bangka Raya No. 4, Pela Mampang Email :
Jakarta 12720, Indonesia
Chapter Headings US $ Select All
Industry Outlook 60.50
Key Statistics 60.50
Market Characteristics 36.30
Segmentation 36.30
Industry Conditions 60.50
Industry Performance 60.50
Key Competitors 60.50
Key Factors 27.50
Two Indonesian Hand Instruments of Ratification 0.39
About Vaccines, BPOM Overseeing Seven Pharmaceutical Wholesalers 0.39
Lautan Luas Immediate Expansion Creamer Factory for US $ 30 Million 0.39
AKR Corporindo Has Secured Fund Requirements for 2018 0.39
Kimia Farma Will Rights Issue Next Year, http 0.39
Kimia Farma Net Income Sped up to112%, http 0.39
PT. Lautan Luas Injecting The Fund for Subsidiaries Amounting to Rp.7,99 Billion 0.39
Eterindo Wahanatama Takes over US $70 Million Land 0.39
Kimia Farma Develops Biotechnology Products 0.39
Kimia Farma's Net Profit Increases 0.39
Enseval Settles US$ 30.7 Million Debt 0.39
Lautan Luas Prepares Rp.130 Billion Capex 0.39
Millenium Pharmacon Targets Sales to Increase 17 Percent 0.39
Eterindo's Financial Report Overdue 0.39
AKR Corporindo Liquidates Subsidiary 0.39
Lautan Luas Expands to Three Countries 0.39
Lautan Luas Establishes Subsidiary 0.39
Kalbe, Dankos, and Enseval Merger Approved 0.39
Lautan Luas Cancels Subsidiary Establishment 0.39
Lautan Builds Company in China 0.39
AKR Corporindo Books Profit Increase 0.39
AKR Corporindo Net Profit Rockets 0.39
40 percent budget of Health Insurance for the Poor to be Allocated for Medicines 0.39
Millenium Pharmacon's Profit Declines Due to Exchange Rate Loss 0.39
Indonesian Pharmaceutical Industry Requires More Research Funds in Order to Compete 0.39
Public Hospitals Obliged to give Generic Medicines to Patients 0.39
Chemical and Pharmaceutical Industry Attracts More Foreign Investors 0.39
Eterindo to Produce Bio-diesel 0.39
Reduced Price of Generic Medicines Will Not Affect PT. Indofarma's Revenue 0.39
Traditional Medicines and Health Supplement Needs Standardisation 0.39

Report Content

The Pharmaceutical, Chemical and Cosmetic Wholesaling industry in Indonesia research report contain trend analysis, statistics, market size information, industry growth rates as well as major competitors.

Major market segments are identified and also those forces affecting demand and supply within this industry. Performance analysis includes emerging industry trends as well as recent results and performance of each key company. Drawing on the depth of information DIS also provides 5 year forecasts for this industry.

The comprehensive study also examines details such as the barriers to entry, operating cost structure, technology & systems and domestic & international markets. Tables and statistics include: Industry revenue, exports, imports, wages and number of companies in the industry, Industry growth and geographic regional data.

KEY STATISTICS 2014 2015 2016 2017 2018
Industry Revenue 107,942 104,367 131,689 158,085 169,151 Rp.Billion
Industry Gross Product 7,016 6,784 8,560 10,276 10,995 Rp.Billion
Number of Establishments 110 120 130 130 130 Units
Employment 109,600 101,200 85 81,000 85,400 Units
Exports 2,856 3,457 6,481 6,521 7,820 Rp.Billion
Imports 10,926 10,899 25,482 30,419 35,880 Rp.Billion
Total Wages 1,425 1,316 1,114 1,010 1,109 Rp.Billion
Domestic Demand 116,012 111,809 150,690 181,983 197,211 Rp.Billion
The data above is sample data only

Cost of Goods Sold 67.13 Gross Profit 32.87
Operating Expense 21.5 Profit (Loss) Before Tax 11.36
Administration 1.58 Depreciation 0.56
Electricity 0.66 Freight 1.99
Fuel, Parking, Toll & Retribution 1.62 Interest 3.09
Land and Building Rental 2.74 Marketing 2.69
Repairs and Maintenance 0.54 Service Fee 0.7
Staff Welfare Allowance 1.38 Other Expenses 0.92
Stationery & Inventory 0.48 Telephone 0.8
Utensils and Equipment 1.24 Wages and Salaries 0.5
The data above is sample data only

Central Java 13.4 DKI Jakarta 6.5
East Java 22.4 North Sumatra 17.9
Papua 2.0 Bali 3.0
South Sulawesi 6.0 West Java 28.8
The data above is sample data only
Price 500.007.750.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

Selective Member`s Discount Price
To become a Selective Member
Table of Contents
About this Report
Key Statistics
Market Characteristics
Industry Conditions
Key Factors
Key Competitors
Industry Performance